Fact-checked by Grok 2 weeks ago

Prallethrin

Prallethrin is a synthetic , chemically known as (2-methyl-4-oxo-3-prop-2-ynylcyclopent-2-en-1-yl) 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate, with the molecular formula C₁₉H₂₄O₃ and a molecular weight of 300.4 g/mol. Introduced in 1988 by in , it is classified as a Type II pyrethroid and is widely used for rapid knockdown and control of indoor pests including mosquitoes, houseflies, , , fleas, and ticks in residential and settings. Prallethrin is formulated in various products such as aerosols, vaporizers, fogging concentrates, oils, and foams, often applied via space sprays or direct contact methods to target flying and crawling insects. It acts on the nervous system of insects by disrupting sodium channel function, leading to paralysis and death, and is valued for its low mammalian toxicity due to rapid metabolism in warm-blooded animals. The compound exhibits moderate solubility in water (8.03 mg/L at pH 7 and 20°C) and high lipophilicity (log P = 4.49), which contributes to its persistence in environmental compartments but also limits its volatility (vapor pressure: 4.2 mPa at 25°C). From a safety perspective, prallethrin is rated as WHO Class II (moderately hazardous), with acute oral LD₅₀ values around 460 mg/kg in rats and dermal LD₅₀ exceeding 5000 mg/kg, indicating low risk from skin contact but potential harm if swallowed or inhaled. It poses significant ecotoxicological risks, being highly toxic to aquatic organisms (e.g., fish LC₅₀: 0.012 mg/L; Daphnia EC₅₀: 0.0062 mg/L) and bees (contact LD₅₀: 0.026 μg/bee), necessitating careful application to avoid environmental release. Regulatory approvals include use in the United States under EPA oversight, with tolerances established for residues in food-handling areas, though it is not approved in the European Union or Great Britain; however, in 2024 the EU approved it for use in biocidal products of product-type 18 (insecticides, acaricides and products to control other arthropods), effective from 1 March 2026.

Chemical properties

Molecular structure

Prallethrin is a synthetic with the molecular formula C₁₉H₂₄O₃ and a of 300.40 g/mol. Its IUPAC name is (S)-2-methyl-4-oxo-3-prop-2-yn-1-ylcyclopent-2-en-1-yl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate. Prallethrin is a complex chiral comprising eight stereoisomers, with the technical material consisting mainly of the [1R,trans;S] and [1R,cis;S] forms in an approximate 4:1 ratio. It bears a close structural resemblance to natural pyrethrins, particularly pyrethrin I, through its core linkage between a substituted cyclopentenone (pyrethrolone-like) and a dimethylcyclopropane .

Physical characteristics

Prallethrin is a yellowish-brown oily at . Its is -25°C, indicating it remains under typical ambient conditions, while the is 313.5°C at 760 mmHg. These thermal properties facilitate its handling as a stable in formulations without requiring specialized heating or cooling. The compound exhibits low , with a of 0.64 at 20°C. This low contributes to minimal during storage and application. The constant is 0.010 Pa m³ mol⁻¹ at 25°C, reflecting limited partitioning into the gas phase from aqueous systems. Prallethrin has low in , at 8.03 mg/L at 20°C and 7, which limits its dissolution in aqueous environments. In contrast, it is highly soluble in organic solvents, exceeding 500,000 mg/L in , , and at 20°C. The (log P) is 4.49 at 20°C and 7, underscoring its high , which arises from the non-polar nature of its molecular structure.

History and development

Discovery

Prallethrin was first synthesized in 1961 as a propargyl analogue of allethrin by researchers Gershoff and Piquett at the U.S. Department of Agriculture (USDA). It was later developed further as a synthetic by researchers at Company Limited in , with key contributions from Noritada Matsuo and colleagues during the late and early . This work built upon the natural pyrethrins, insecticidal compounds isolated from flowers in the 1940s, and the broader class pioneered through USDA efforts in synthesizing stable analogs like allethrin. The focus was on enhancing knockdown activity for household insect control, addressing limitations in potency and volatility of earlier compounds. Sumitomo's improvements included of the active (S)- moiety by 1981 and practical by 1988, esterified with (1R)-trans-chrysanthemic to yield the potent (S)-2-methyl-4-oxo-3-propargylcyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate. This adjustment improved and insecticidal potency, particularly against flying pests like mosquitoes and flies. The closely mimics natural I while offering greater efficacy, with the propargyl substitution enhancing the compound's volatility and rapid action compared to allyl-based predecessors. Initial laboratory testing demonstrated prallethrin's superior rapid excitation and lethal effects on target , achieving 20 times the activity of natural pyrethrins against female houseflies (LD50: 0.043 µg per insect). It exhibited high knockdown and killing rates for mosquitoes (Culex pipiens) and flies (Musca domestica), outperforming earlier pyrethroids in speed and completeness of incapacitation. Early evaluations emphasized its potential for household applications, with fourfold greater efficacy than allethrin against houseflies. Sumitomo Chemical secured patents for prallethrin in the 1970s, with foundational research published in 1980 highlighting its advantages over compounds like allethrin in terms of potency and selectivity for household pests. These publications, including detailed chemical syntheses and bioassays, underscored the compound's role in advancing evolution for non-agricultural use.

Commercialization

Prallethrin was first commercialized in in 1988 by Company, marking the introduction of this synthetic as a potent for household applications. Developed to address limitations of earlier pyrethroids, it quickly gained traction due to its enhanced knockdown efficacy against flying insects, enabling rapid control in indoor environments. The compound's expansion into global markets accelerated in the 1990s, with the registering the first prallethrin-containing product in 1994 for household pest control uses. This registration supported its adoption as a safer alternative to organophosphates, which faced increasing regulatory scrutiny for their higher mammalian toxicity and environmental persistence. In , early adoption focused on . By 2004, the established specifications for prallethrin technical concentrate and formulations, based on data submitted by , facilitating its standardized use in programs worldwide. This endorsement underscored prallethrin's role in bridging the gap between efficacy and safety in markets transitioning from older chemical classes.

Mechanism of action

Effects on insects

Prallethrin is classified as a Type I , characterized by the absence of an alpha-cyano group in its chemical structure. This classification distinguishes it from Type II pyrethroids, which possess the cyano moiety and often produce more prolonged neurotoxic effects. As a synthetic analog of natural pyrethrins derived from flowers, prallethrin exhibits enhanced stability and potency while retaining a similar mode of insecticidal action. The primary mechanism of prallethrin involves to voltage-gated sodium channels in the nerve axons of , which prolongs the open state of these channels and disrupts normal . This leads to repetitive spontaneous nerve firing, resulting in hyperexcitation of the . exposed to prallethrin display symptoms such as uncoordinated movements and tremors, progressing to , known as knockdown, which immobilizes them rapidly. For flying like mosquitoes and houseflies, knockdown typically occurs within minutes of contact exposure. Prallethrin demonstrates high potency against a range of household pests, achieving effective control at low concentrations. For instance, formulations containing 1.6% prallethrin are sufficient for rapid knockdown and mortality in mosquitoes via vaporized delivery. It is similarly efficacious against , , and wasps, where low doses induce and subsequent lethality. The knockdown effect provides immediate immobilization, while death follows from sustained leading to , as affected insects are unable to maintain vital functions. This dual action—rapid incapacitation followed by fatality—makes prallethrin particularly valuable for quick pest management in enclosed environments.

Selectivity to non-target organisms

Prallethrin, like other s, exhibits selective primarily due to its higher affinity for voltage-gated sodium s compared to those in vertebrates, influenced by structural differences in the channels and physiological factors such as insects' smaller body size and ectothermic nature. Insects' smaller size results in higher effective concentrations per unit body weight upon exposure, while their lower body temperature (typically around 25°C) enhances pyrethroid binding and action on sodium channels, as pyrethroid potency increases at cooler temperatures due to slower . This temperature-dependent selectivity contributes to prallethrin's greater neurotoxic effects in than in endothermic mammals and , whose higher body temperatures (around 37°C) reduce the duration of channel modification. In mammals, prallethrin undergoes rapid through by enzymes and oxidation by oxidases, primarily in the liver, leading to quick elimination and minimized . This metabolic efficiency contrasts with , where such enzymes are less active or present in lower amounts, prolonging the insecticide's effects. The lipophilic nature of prallethrin facilitates its penetration through the waxy insect cuticle, allowing effective contact , but in warm-blooded animals, it promotes rapid distribution followed by swift enzymatic breakdown, further enhancing selectivity. Quantitative measures underscore this selectivity: prallethrin's acute oral LD₅₀ is 1171 mg/kg in bobwhite quail and >2000 mg/kg in ducks, indicating low avian potency, whereas it is highly toxic to , with a contact LD₅₀ of 0.026 μg/. However, exceptions exist among non-target organisms; aquatic invertebrates show high sensitivity due to their ectothermic and slower at lower temperatures, resulting in prolonged and accumulation.

Uses and applications

Household pest control

Prallethrin is widely employed in household settings for the control of indoor pests, particularly through consumer-available products designed for safe and effective application in living spaces. Its primary role targets common household invaders, leveraging its properties for rapid insect incapacitation without prolonged environmental persistence indoors. For flying insects such as mosquitoes, flies, wasps, and hornets, prallethrin is commonly formulated in sprays and electric vaporizers that disperse the as a fine or vapor throughout enclosed areas. These methods allow for treatments that quickly contact and affect airborne pests, achieving knockdown within seconds to minutes by disrupting their nervous systems through interference. Prallethrin also demonstrates effectiveness against crawling pests including , , and spiders, typically applied via surface treatments in cracks, crevices, and along baseboards. Direct spraying onto infested areas or pathways provides contact control, with the insecticide's enabling initial rapid action followed by limited efficacy lasting hours to days on treated surfaces. Application in homes emphasizes direct spraying for localized infestations and broader space treatments for room-wide control, often featuring low-odor formulations to minimize disruption and enhance indoor tolerability. This approach supports safe re-entry shortly after use, as the short residual activity reduces prolonged exposure risks in residential environments. Prallethrin's advantages include its fast knockdown, which provides immediate relief from active pests, and its suitability for indoor applications due to low mammalian toxicity at use levels. In ready-to-use household products like aerosols and vaporizers, prallethrin is typically incorporated at concentrations ranging from 0.05% to 0.4% to balance efficacy with safety for residential pest management.

Public health vector control

Prallethrin is employed in vector control programs to mitigate the transmission of mosquito-borne diseases such as , dengue, and in tropical and subtropical regions, where vectors like and species thrive in urban and peri-urban environments. As a synthetic , it serves as a spatial repellent and quick-knockdown agent, disrupting host-seeking behavior and reducing human-vector contact in community settings. Its application targets adult mosquitoes, complementing larval control measures in integrated vector management strategies aimed at disease prevention. Key deployment methods include ultra-low (ULV) fogging and space spraying in public areas, such as parks, , and residential neighborhoods, to create protective barriers against flying adults. Products like Cielo ULV and AquaDuet, which contain prallethrin combined with synergists, are applied via truck-mounted or handheld sprayers to achieve broad coverage with minimal . These techniques are particularly suited for rapid response during outbreaks, dispersing fine droplets that remain to intercept mosquitoes. Efficacy trials demonstrate prallethrin's high knockdown rates against Aedes albopictus and Anopheles species, with open-field ULV applications achieving 95.6% initial knockdown and over 99% mortality within 24-72 hours post-exposure. Laboratory and semi-field studies further indicate significant reductions in mosquito landing and biting rates, effectively lowering vector-human interactions in treated areas. Field evaluations report substantial decreases in mosquito entry into protected spaces, supporting its role in suppressing biting rates under operational conditions. Prallethrin integrates into broader frameworks as an alternative or adjunct to indoor residual spraying (IRS), particularly in areas with resistance, by enabling outdoor and rapid-intervention applications that avoid direct surface treatments. The (WHO) prequalifies prallethrin-based space sprays for use in and dengue programs, emphasizing their for repellency and movement disruption in resistance-prone settings. This aligns with WHO guidelines for spatial repellents, which prioritize non-lethal effects to complement long-lasting insecticidal nets in integrated approaches. Since the 1990s, prallethrin has gained prominence in urban vector management across and , driven by rising dengue and Zika incidences in densely populated areas. In countries like and , it supports national programs through space spraying to curb Aedes aegypti outbreaks, while in , it aids control amid urbanization challenges. Its adoption reflects a shift toward pyrethroid-based tools for scalable, community-level interventions in these high-burden regions.

Formulations and products

Common formulations

Prallethrin is commonly formulated as aerosols and sprays in pressurized cans, designed for direct application to achieve rapid knockdown of target . These formulations typically contain 0.1% to 0.5% (ai), allowing for effective dispersion in indoor environments without requiring dilution. The low concentration ensures quick and minimal residue, leveraging prallethrin's high for immediate efficacy. Liquid vaporizer formulations are widely used in electric diffusers, where the is released as a vapor over extended periods, typically 8 to 12 hours, to provide continuous protection in enclosed spaces. A standard concentration is 1.6% w/w, which facilitates steady through a mechanism when heated. This form is particularly suited for household applications due to its low odor and even distribution. Emulsifiable concentrates (ECs) of prallethrin are prepared for use, often diluted in fogging equipment to generate fine mists for broader coverage. These liquid formulations mix oil-based active ingredients with emulsifiers, enabling stable dilution in water at ratios that achieve desired application rates, such as in ultra-low volume (ULV) foggers. ECs support targeted treatments in larger areas while maintaining the insecticide's potency during mixing and application. Foam formulations incorporate prallethrin for precise delivery into cracks and crevices, expanding upon application to penetrate hard-to-reach areas against crawling . These are typically ready-to-use, with the suspended in a that provides and slow release. is a key consideration in prallethrin formulations, as the compound is susceptible to degradation from , , and photolysis. Manufacturers incorporate stabilizers, such as antioxidants or UV protectants, to maintain during storage and use, particularly in tropical climates. Prallethrin's low water (8.03 mg/L) and high (log Kow = 4.49) aid in creating robust emulsions and suspensions that resist .

Notable commercial products

Prallethrin serves as a key in various branded insecticides, particularly those targeting household pests in specific regional markets. , manufactured by SC Johnson, features prallethrin in its vaporizer mats and liquid formulations designed for , with widespread availability in and other Asian countries. GoodKnight Silver Power, produced by Godrej, incorporates 1.6% prallethrin in its liquid vaporizer for household repellent applications, achieving significant in . In the United States, Hot Shot Ant & Roach Killer sprays from contain 0.025% prallethrin combined with germicides, targeting ants, roaches, and related crawling insects for indoor use. Raid Flying Insect Killer aerosol, also by SC Johnson, includes 0.10% prallethrin to address wasps, flies, and other flying pests, primarily distributed in . These products reflect prallethrin's dominant market presence in —such as and —alongside availability in the , while its application is not yet permitted in the , with approval effective March 1, 2026, under biocidal regulations.

Toxicology

Mammalian toxicity

Prallethrin demonstrates moderate acute oral in rats, with reported LD₅₀ values of 640 mg/kg in males and 460 mg/kg in females, classifying it as WHO Hazard Class II moderately hazardous. Acute dermal is low, with an LD₅₀ exceeding 5000 mg/kg in rats, indicating minimal absorption through the skin. For , the LC₅₀ is approximately 0.29 mg/L over a 4-hour in rats, reflecting moderate via this route. In the 90-day subchronic study in rats, prallethrin caused decreased body weight gain, reduced food consumption, and increased arousal activity, with a LOAEL of 363 mg/kg/day in males and 420 mg/kg/day in females. No was observed. These effects align with prallethrin's mechanism of prolonging opening in neuronal membranes, leading to hyperexcitation at elevated exposures. No such was evident at the NOAEL of 74 mg/kg/day in males and 88 mg/kg/day in females. Chronic toxicity studies in rats and mice show no evidence of carcinogenicity, with NOAELs of 83.5 mg/kg/day in male rats and 68 mg/kg/day in male mice, and the compound classified as "not likely to be carcinogenic to humans" by the EPA. assays, including bacterial mutation and chromosomal aberration tests, are predominantly negative, indicating no mutagenic potential. Reproductive and developmental studies in rats and rabbits reveal no increased susceptibility in offspring, with developmental NOAELs up to 300 mg/kg/day and no teratogenic effects observed. Prallethrin undergoes rapid in the liver, primarily via , with a supporting within 48 hours and minimal .

Human health effects

Prallethrin primarily enters the through of vapors or aerosols during application and dermal contact with sprays or residues, while poses a low risk under typical use conditions. Occupational handlers and residential users face the highest exposure potential via these routes, but regulatory assessments indicate no significant risks when (PPE) such as gloves and respirators is used. Acute exposure to prallethrin can cause minimal eye classified as EPA Toxicity Category IV, resulting in temporary redness or discomfort, while it is non-irritating to (Category IV) and not a dermal sensitizer. At higher exposure levels, symptoms may include headaches, , , and muscle twitching due to its action on sodium channels, though these are rare in standard applications and resolve with supportive care. of concentrated vapors can lead to respiratory , particularly in enclosed spaces. Chronic exposure risks are minimal, with the U.S. Environmental Protection Agency (EPA) classifying prallethrin as "not likely to be carcinogenic to humans" based on no observed tumors in long-term studies, and no evidence of mutagenicity or at relevant doses. Dietary and residential aggregate exposures show margins of exposure well above levels of concern, supporting the reduction of the Food Quality Protection Act safety factor to 1x for all populations. Occupational exposure is considered safe when and PPE are implemented, with no neurotoxic effects reported in humans at recommended application rates; mitigation measures like chemical-resistant gloves and half-face respirators address identified handler risks. Vulnerable groups, including children and individuals with , may experience heightened respiratory irritation from exposure, though overall risks remain low and no specific concerns were identified in aggregate assessments. Prallethrin is rapidly metabolized in mammals via ester and oxidation, contributing to its low persistence in the body.

Environmental impact

Ecotoxicity to aquatic life

Prallethrin exhibits high to , with a 96-hour LC₅₀ of 0.012 mg/L reported for (Oncorhynchus mykiss), classifying it as highly toxic to this species under standard testing conditions. This sensitivity underscores the potential for lethal effects on populations from short-term exposures in contaminated waters. Invertebrates such as the water flea () are similarly vulnerable, showing an acute 48-hour EC₅₀ of 0.0062 mg/L, indicating immobilization in over half the population at low concentrations. Chronic exposure further highlights risks, with a 21-day no-observed-effect concentration (NOEC) greater than 0.00065 mg/L, suggesting sublethal impacts like reduced may occur at trace levels over extended periods. Despite a log Kow of 4.49 indicating high , prallethrin's potential in organisms remains low due to rapid metabolic degradation. However, its low water solubility (approximately 8 /L) contributes to a high in systems via runoff, where it can sorb to sediments and persist, prolonging risks to benthic organisms.

Ecotoxicity to terrestrial species

Prallethrin demonstrates very high acute toxicity to bees, with a contact LD50 of 0.026 μg/bee for Apis mellifera, classifying it as highly hazardous to pollinators and necessitating avoidance of applications during active foraging periods to minimize exposure. This sensitivity arises from the pyrethroid's mode of action, which disrupts sodium channels in insect nervous systems, leading to rapid paralysis and death even at low doses. In contrast, prallethrin exhibits low to , evidenced by an oral LD50 greater than 2000 mg/kg body weight in species such as the mallard duck (Anas platyrhynchos), indicating minimal direct risk to avian populations under typical exposure scenarios. Dietary studies further support this low hazard profile, with no observed adverse effects at environmentally relevant concentrations. Prallethrin poses low risk to , classified as practically non-toxic in soil toxicity assessments, preserving and functions in treated areas. Among non-target insects, prallethrin can induce high mortality in beneficial species, including predatory arthropods like ladybird beetles, particularly if oversprayed beyond targeted applications, disrupting natural dynamics. Effects on terrestrial plants are minimal, with no significant reported and no direct adverse impacts on crop growth or yield observed in standard evaluations.

Fate and regulation

Environmental degradation

Prallethrin degrades rapidly via when exposed to , particularly in aqueous environments, with a pseudo-first-order of 13.6 hours in sterile buffered at 5 and temperatures of 22–27 °C. On surfaces, however, proceeds more slowly, with of 24.8–26.9 days under similar exposure conditions, yielding products such as , chrysanthemic acid, and polar glassy liquids (PGLs). Hydrolysis of prallethrin is negligible under neutral and acidic conditions, remaining stable with no significant observed over 30 days at 5 or 7 and 25 °C, corresponding to a exceeding one year at 7. In alkaline environments, accelerates, with a of 4.9 days (118 hours) at 9 and 23.5–25 °C. In , prallethrin undergoes aerobic primarily through microbial processes, with a DT50 of 9 days in sandy loam soil at 20–25 °C, ultimately mineralizing to CO2 and forming bound residues. aquatic is slower, with an upper-bound of 37 days. Prallethrin demonstrates low mobility in , characterized by a soil organic carbon adsorption coefficient (Koc) of 2,533 L/kg, indicating strong adsorption to and minimal leaching potential. Its log Pow of 4.49 (at 25 °C) further supports limited partitioning into water phases relative to solids. Atmospheric persistence of prallethrin is limited by its low volatility ( of 2.2 × 10−5 mm at 25 °C), resulting in negligible long-range transport. Any volatilized prallethrin in the gas phase would degrade quickly via indirect photolysis, with estimated half-lives of approximately 2 hours against hydroxyl radicals and 18 minutes against .

Regulatory status

In the United States, prallethrin is approved by the Environmental Protection Agency (EPA) for use as an , with established tolerances of 1.0 parts per million () for residues, including its metabolites and degradates, in or on all commodities. The EPA's Interim Registration Review Decision in 2020 confirmed the safety of these tolerances and existing uses, determining no significant risks to human health or the under labeled conditions. Prallethrin was commercially introduced in Japan in 1988 and remains widely used there as a pyrethroid insecticide without major restrictions, primarily in household and public health applications. In the European Union and United Kingdom, prallethrin is not approved under Regulation (EC) No 1107/2009 for use in plant protection products. However, it is permitted in biocidal products under the Biocidal Products Regulation (EU) No 528/2012, with approval for product-type 18 (insecticides) effective from March 1, 2026, following submission of required dossiers by industry. In September 2025, the European Chemicals Agency (ECHA) clarified that a dietary risk assessment is required for all prallethrin-containing biocidal products, impacting dossier preparations for continued authorization. The (WHO) classifies prallethrin as moderately hazardous (Class II) based on its profile and has established specifications for its technical-grade material and formulations intended for , such as . As of November 2025, prallethrin meets the FAO's criteria for highly hazardous pesticides due to its WHO Class II status and ecotoxicological concerns.

References

  1. [1]
    Prallethrin | C19H24O3 | CID 9839306 - PubChem - NIH
    The WHO Recommended Classification of Pesticides by Hazard identifies prallethrin (technical grade) as Class II: moderately hazardous; Main Use: insecticide.
  2. [2]
    Prallethrin (Ref: OMS 3033) - AERU - University of Hertfordshire
    Pesticide properties for Prallethrin, including approvals, environmental fate, eco-toxicity and human health issues.
  3. [3]
    [PDF] US EPA - Prallethrin Interim Registration Review Decision
    Sep 29, 2020 · review timeline for prallethrin. • August 2019 – The Agency published the USEPA Office of Pesticide Programs' Re-. Evaluation of the FQPA ...Missing: manufacturer history<|control11|><|separator|>
  4. [4]
  5. [5]
    [PDF] 2-methyl-4-oxo-3-prop-2-ynylcyclopent-2-enyl(1R)
    Prallethrin is a racemic mixture of 8 stereoisomers, mainly [1R,trans; S] and [1R,cis; S] in a 4:1 ratio, with chemical formula C19H24O3.
  6. [6]
    Prallethrin (Ref: OMS 3033) - AERU
    Prallethrin is a complex chiral molecule. The technical material is an isomeric mixture of 8 stereoisomers but consists mainly of [1R,trans; S] and [1R,cis; S] ...
  7. [7]
    Discovery and development of pyrethroid insecticides - PMC - NIH
    Itaya re-designed the structure of the alcohol moiety of prallethrin (see Section 2.3. 3) in a manner analogous to tetramethrin. He eventually succeeded by ...
  8. [8]
    One Hundred Years of Pyrethroid Chemistry: A Still-Open Research ...
    This paper aims to provide an exhaustive review of the historical research pathways and relative turning points that led to the discovery and mass production ...
  9. [9]
  10. [10]
    Characterization of residential pest control products used in ... - NIH
    In 2001, the EPA withdrew the registration of chlorpyrifos for indoor and outdoor residential use, limiting use to certified agricultural operators and a ...Missing: Prallethrin | Show results with:Prallethrin
  11. [11]
  12. [12]
    Dengue: The Risk to Developed and Developing Countries
    The geographic expansion of epidemic dengue fever during the 1980s involved South, Central, and North America; Africa; China; and Australia, and is expected to ...
  13. [13]
    [PDF] Prallethrin. Human Health Risk Assessment for the Tolerance ...
    Sep 15, 2014 · There are no human health risk concerns associated with the proposed label amendment. The established tolerance of 1.0 ppm for the use of ...
  14. [14]
    PYRETHRINS AND PYRETHROIDS - EXTOXNET PIP
    Symptoms may also include incoordination, tremors, convulsions, paralysis, respiratory failure, and death. Pyrethroids can cause two quite different ...
  15. [15]
    Current Research on the Safety of Pyrethroids Used as Insecticides
    They are 2250 times more toxic to insects than to vertebrates due to insects' smaller size, lower body temperature and more sensitive sodium channels. In ...
  16. [16]
    Thermal Stress and Toxicity - Gordon - 2014 - Wiley Online Library
    Jul 1, 2014 · Summary of Factors Contributing to Selective Toxicity of Pyrethroids in Insects and Mammals ... * Assuming that body temperature of insects is 25° ...
  17. [17]
    Pyrethroids: mammalian metabolism and toxicity - PubMed
    Apr 13, 2011 · They showed that ester hydrolysis and oxidation play predominant roles in mammalian metabolism of pyrethroids and that rapid metabolism leads to low mammalian ...
  18. [18]
    Pyrethroids and Their Effects on Ion Channels - IntechOpen
    Pyrethroid insecticides target VGSCs, but also affect the function of voltage-gated calcium and voltage-gated chloride channels.
  19. [19]
    [PDF] Prallethrin - Amazon S3
    May 14, 2012 · Single-dose toxicity testing indicates that prallethrin is low in toxicity to birds and moderately toxic to animals but highly toxic to bees, ...
  20. [20]
    Toxicological impacts of synthetic pyrethroids on non-target aquatic ...
    Synthetic pyrethroids are metabolized and eliminated at a slower rate in fish compared to birds and mammals and this may be the reason for their observed ...
  21. [21]
    [PDF] Sumitomo Chemical
    Kills all types of pests flies, mosquitoes, gnats, cockroaches, ants, wasps, hornets, ticks, fleas, spiders and other household insect pests. Broad range of ...<|separator|>
  22. [22]
  23. [23]
    [PDF] An Expert Review of Spatial Repellents for Mosquito Control
    Sumitomo Chemical Company, for example, has developed a metofluthrin (SumiOne®) based product that lasts for roughly 6 to 8 weeks and has knockdown effects on ...
  24. [24]
    Pesticides Used To Control Adult Mosquitoes | US EPA
    Oct 1, 2025 · State and local agencies commonly use the organophosphate insecticides malathion and naled and the synthetic pyrethroid insecticides prallethrin, etofenprox, ...
  25. [25]
    [PDF] Global insecticide use for vector-borne disease control
    The main vector-borne diseases are malaria, dengue, leishmaniasis, Chagas disease, lymphatic filariasis, onchocerciasis, Zika virus disease, yellow fever, ...
  26. [26]
    Vector Control Product List - World Health Organization (WHO)
    Vector Control Product List ; 020-006 · Cielo ULV, Clarke International, Space Spray (indoor), Space Spray (outdoor), Imidacloprid, Prallethrin ; 025-002 · Device ...
  27. [27]
    [PDF] duet.pdf - Clarke Mosquito Control
    Duet is a quick knockdown, oil-soluble pyrethroid for controlling adult mosquitoes, gnats, midges, and blackflies. It contains Prallethrin, Sumithrin, and ...
  28. [28]
    An Open-Field Efficacy Trial Using AquaDuet™ via an Ultra-Low ...
    Aug 9, 2025 · We conducted an open-field ultra-low volume efficacy bioassay using a water-based formulation AquaDuet (prallethrin [1%], sumithrin [5%], ...
  29. [29]
  30. [30]
    Prallethrin Market Research Report 2033 - Market Intelo
    In Latin America, countries like Brazil and Mexico are investing heavily in vector control programs, while in Africa, international health organizations are ...
  31. [31]
    Global Prallethrin Market: Size And Trends - LinkedIn
    Jul 24, 2025 · High-growth regions, notably Asia-Pacific and Latin America, are witnessing rapid adoption due to increasing urbanization, rising insect ...
  32. [32]
    Recent trends in global insecticide use for disease vector control ...
    Dec 13, 2021 · In the Asia–Pacific, reported insecticide use for dengue—which was for 40.4% by residual spraying, 33.2% larviciding and 26.4% space spraying ( ...Missing: prallethrin | Show results with:prallethrin
  33. [33]
    Prallethrin - Environmental Protection Agency (EPA)
    Missing: 0.1-0.5% | Show results with:0.1-0.5%
  34. [34]
    [PDF] Prallethrin. Revised Draft Human Health Risk Assessment for ...
    Nov 16, 2016 · The adverse outcome pathway (AOP) shared by pyrethroids involves the ability to interact with voltage-gated sodium channels (VGSCs) in the ...
  35. [35]
    [PDF] Discovery and Development of a Novel Pyrethroid Insecticide ...
    Momfluorothrin is an exciting novel pyrethroid discovered by Sumitomo Chemical Co., Ltd. Momfluorothrin exhibited excellent knockdown activity which is ...Missing: 1980s | Show results with:1980s<|control11|><|separator|>
  36. [36]
    Prallethrin - Endura
    The most recommended uses of PRALLETHRIN are in coils, mats, liquid emanator devices, aerosols, liquid concentrates (emulsifiable concentrates, macro-and micro- ...Missing: foam concentrations
  37. [37]
    Pesticide Formulations - Ask IFAS - University of Florida
    An emulsifiable concentrate formulation usually contains a liquid active ingredient, one or more petroleum-based solvents (which give EC formulations their ...Missing: Prallethrin foam
  38. [38]
    Synthetic and Natural Insecticides: Gas, Liquid, Gel and Solid ...
    Its structure follows the traditional insecticide categorization based on four physical formulation types: gas, liquid, gel/foam, and solid. The review ...
  39. [39]
    All Out maker to sell majority stake in local unit to Bansk
    Feb 11, 2021 · US-based SC Johnson, best known in India as the maker of All Out mosquito repellent and Kiwi shoe polish, has unexpectedly decided to give up majority ...
  40. [40]
    Prallethrin - national analytical corporation - chemical division
    Prallethrin 1.6% w/w liquid vaporizer is a repellent insecticide generally used for the control of mosquitoes in households.
  41. [41]
    Pesticide - Goodknight Mosquito Repellent- LiquidVapourizer
    Active Ingredients: Prallethrin. Percentage Active Ingredients: 1.6. Form: Solid. Use: Domestic. Toxicity Class: IV. Status: Registered Applicant in Trinidad ...
  42. [42]
    Ant Killer Plus₄ - Hot Shot
    Hot Shot® Ant Killer Plus kills ants indoors and outdoors, including ... Prallethrin:0.025%. Lambda-Cyhalothrin:0.030%. Other Ingredients:99.945%. Total ...
  43. [43]
    Raid® Flying Insect Killer - What's Inside SC Johnson
    Prallethrin. Emulsifier. Ensures even distribution of the ingredients in a product. Other Ingredients ...
  44. [44]
    Prallethrin PT18: Active Substance Compliance Obligations 2026
    Nov 12, 2024 · The approval of prallethrin for PT18 introduces new regulatory requirements for manufacturers and distributors. To continue marketing products ...
  45. [45]
    [PDF] Cielo ULV Adulticide Space Spray - WHO/OMS: Extranet Systems
    4.2.1 Mammalian Toxicity a). Prallethrin. • Acute Toxicity ... Imidacloprid given orally as a single dose was moderately toxic to rats (LD50 = 424–650 mg/kg bw; ...
  46. [46]
    Prallethrin; Pesticide Tolerances - Federal Register
    Oct 29, 2014 · EPA assessed potential residential handler exposure scenarios resulting from mixing/loading/applying sprays to lawns using hose-end and backpack ...
  47. [47]
    [PDF] 1R-trans Prallethrin, and Related End-use Products
    Nov 23, 2018 · In acute toxicity testing in rats, 1R-trans prallethrin was highly toxic via the oral route of exposure, of low toxicity via the dermal route, ...
  48. [48]
    [PDF] May 26, 2005 MEMORANDUM SUBJECT: Reassessment of the ...
    Environmental Fate Data Requirements for: Prallethrin ... Second, prallethrin's anaerobic aquatic metabolism ... Aerobic Soil Metabolism asm. 9 days. Halfife.
  49. [49]
    7 months remain until the approval of prallethrin | BPR - Nordiik
    May 22, 2025 · March 1, 2026, is the deadline for its approval, which means there are just seven months left before this important regulatory change comes into ...Missing: restricted | Show results with:restricted<|separator|>
  50. [50]
    [PDF] PAN International List of Highly Hazardous Pesticides
    The FAO definition of an HHP includes pesticides linked with a high incidence of severe or irreversible adverse effects on human health or the environment.